US health officials will likely approve a 3rd COVID “booster” shot after 6 months instead of 8 months following “full vaccination.”
Because “full vaccination” does not actually mean “full vaccination” and the medical elites are now promoting three shots — until they start promoting four shots.
U.S. health regulators could approve a third COVID-19 shot for adults beginning at least six months after full vaccination, instead of the previously announced eight-month gap, the Wall Street Journal reported on Wednesday.
Approval of boosters for three COVID-19 shots being administered in the United States — those manufactured by Pfizer Inc (PFE.N) and partner BioNTech SE (22UAy.DE), Moderna Inc (MRNA.O) and Johnson & Johnson (JNJ.N) — is expected in mid-September, the report said, citing a person familiar with the plans.
Pfizer and BioNTech have already started the application process for the approval of its booster shot in people 16 and older, saying it spurs a more than three-fold increase in antibodies against the coronavirus. read more
Earlier this week, U.S. regulators granted full approval to Pfizer’s two-dose vaccine. Moderna said on Wednesday it has completed the real-time review needed for a full approval for its jab in people 18 and above.